{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:16:44Z","timestamp":1784719004170,"version":"3.55.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":3139,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007825","name":"American College of Veterinary Dermatology Research Award","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Itraconazole is commonly used for treatment of systemic and cutaneous mycoses in veterinary medicine. Two formulations, capsule and solution, are used interchangeably in dogs. However, marked differences in bioavailability have been reported in other species. Similar investigations have not been performed in dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine and compare pharmacokinetics of itraconazole in dogs after oral administration of commercially available capsule and solution formulations intended for use in humans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Eight healthy, adult, purpose-bred dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Dogs received approximately 10 mg\/kg of innovator-formulated itraconazole solution and capsule PO in randomized, crossover design with a 10-day washout period. To ensure maximal absorption, solution was administered to fasted dogs, whereas capsules were co-administered with food. Blood samples were collected at predetermined time points, and plasma drug concentrations were measured using high-pressure liquid chromatography. Pharmacokinetic parameters were determined with compartmental analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean relative bioavailability of the capsule was 85% that of the solution, but drug absorption was variable, and overall drug concentrations were similar between formulations. Mean elimination half-lives of both formulations were nearly identical at approximately 33 hours. Regardless of formulation, simulations suggest that a loading dose of 20 mg\/kg, followed by 10 mg\/kg once every 24 hours, will result in plasma concentrations considered to be adequate in most dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Contrary to findings reported in other species, overall drug exposures after capsule and solution administration are not substantially different in dogs. Despite some pharmacokinetic differences between itraconazole capsule and solution, formulation-specific dosages do not appear to be necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.14779","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T01:26:43Z","timestamp":1497835603000},"page":"1163-1169","source":"Crossref","is-referenced-by-count":26,"title":["Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator-Formulated Itraconazole Capsules and Solution in Healthy Dogs"],"prefix":"10.1093","volume":"31","author":[{"given":"A.E.","family":"Hasbach","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Small Animal Clinical Sciences, , East Lansing, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-6307","authenticated-orcid":false,"given":"D.K.","family":"Langlois","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Small Animal Clinical Sciences, , East Lansing, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"E.J.","family":"Rosser","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Small Animal Clinical Sciences, , East Lansing, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-7898","authenticated-orcid":false,"given":"M.G.","family":"Papich","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University Molecular Biomedical Sciences Department, , Raleigh, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"2026020303203345200_jvim14779-bib-0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2885.2003.00456.x","article-title":"Antifungal agents of use in animal health \u2013 chemical, biochemical and pharmacological aspects","volume":"26","author":"VandenBossche","year":"2003","journal-title":"J Vet Pharmacol Therap"},{"key":"2026020303203345200_jvim14779-bib-0002","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cvsm.2010.07.006","article-title":"Antifungal treatment of small animal veterinary patients","volume":"40","author":"Foy","year":"2010","journal-title":"Vet Clin Small Anim"},{"key":"2026020303203345200_jvim14779-bib-0003","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ctsap.2005.07.004","article-title":"Epidemiology, diagnosis, and treatment of blastomycosis in dogs and cats","volume":"20","author":"Br\u00f6mel","year":"2005","journal-title":"Clin Tech Small Anim Pract"},{"key":"2026020303203345200_jvim14779-bib-0004","first-page":"579","article-title":"Infectious Disease of the Dog and Cat","author":"Greene","year":"2012","edition":"4"},{"key":"2026020303203345200_jvim14779-bib-0005","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1517\/17425255.2013.794785","article-title":"Itraconazole: An update on pharmacology and clinical use for treatment of invasive and allergic fungal infections","volume":"9","author":"Lester","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2026020303203345200_jvim14779-bib-0006","first-page":"222","article-title":"Small Animal Clinical Pharmacology and Therapeutics","author":"Boothe","year":"2001","edition":"2"},{"key":"2026020303203345200_jvim14779-bib-0007","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2710.2001.00338.x","article-title":"Itraconazole oral solution and intravenous formulations: A review of pharmacokinetics and pharmacodynamics","volume":"26","author":"Willems","year":"2001","journal-title":"J Clin Pharm Ther"},{"key":"2026020303203345200_jvim14779-bib-0008","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2013.12.016","article-title":"Formulation of itraconazole nanocrystals and evaluation of their bioavailability in dogs","volume":"87","author":"De Smet","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"key":"2026020303203345200_jvim14779-bib-0009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jvim.12219","article-title":"Bioequivalence of orally administered generic, compounded, and innovator-formulated itraconazole in healthy dogs","volume":"28","author":"Mawby","year":"2014","journal-title":"J Vet Intern Med"},{"issue":"4","key":"2026020303203345200_jvim14779-bib-0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-200161001-00003","article-title":"Pharmacology of itraconazole","volume":"61","author":"De Beule","year":"2001","journal-title":"Drugs"},{"key":"2026020303203345200_jvim14779-bib-0011","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AAC.37.4.778","article-title":"Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers","volume":"37","author":"Barone","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020303203345200_jvim14779-bib-0012","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002280050438","article-title":"Effect of omeprazole on the pharmacokinetics of itraconazole","volume":"54","author":"Jaruratanasirikul","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"2026020303203345200_jvim14779-bib-0013","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1128\/AAC.42.7.1862","article-title":"Enhanced bioavailability of itraconazole in hydroxypropyl-\u03b2-cyclodextrin solution versus capsules in healthy volunteers","volume":"42","author":"Barone","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020303203345200_jvim14779-bib-0014","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/j.1875-9114.1996.tb02973.x","article-title":"Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole","volume":"16","author":"Van de Velde","year":"1996","journal-title":"Pharmacotherapy"},{"key":"2026020303203345200_jvim14779-bib-0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jac\/dkg089","article-title":"A randomized comparative study to determine the effect of omeprazole on the peak serum concentrations of itraconazole oral solution","volume":"51","author":"Johnson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2026020303203345200_jvim14779-bib-0016","article-title":"Sporanox\u2122 (itraconazole) oral solution: Safety Labeling Changes Approved by FDA Center for Drug Evaluation and Research (CDER)","author":"U.S. Food and Drug Administration"},{"key":"2026020303203345200_jvim14779-bib-0017","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2460\/ajvr.1997.58.08.872","article-title":"Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats","volume":"58","author":"Boothe","year":"1997","journal-title":"Am J Vet Res"},{"key":"2026020303203345200_jvim14779-bib-0018","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/1098612X15581408","article-title":"Pharmacokinetics and bioavailability of itraconazole oral solution in cats","volume":"18","author":"Liang","year":"2016","journal-title":"J Feline Med Surg"},{"key":"2026020303203345200_jvim14779-bib-0019","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J Appl Toxicol"},{"key":"2026020303203345200_jvim14779-bib-0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jvp.12231","article-title":"Alternate-day dosing of itraconazole in healthy adult cats","volume":"39","author":"Middleton","year":"2015","journal-title":"J Vet Pharmacol Therap"},{"key":"2026020303203345200_jvim14779-bib-0021","article-title":"USP 38-NF 33. General chapter 1225. Validation of Compendial Procedures","author":"United States Pharmacopeia (USP-NF)","year":"2015"},{"key":"2026020303203345200_jvim14779-bib-0022","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01117450","article-title":"Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"2026020303203345200_jvim14779-bib-0023","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: Guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2026020303203345200_jvim14779-bib-0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkm389","article-title":"Antifungal serum concentration monitoring: An update","volume":"61","author":"Goodwin","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2026020303203345200_jvim14779-bib-0025","doi-asserted-by":"crossref","first-page":"e0134116","DOI":"10.1371\/journal.pone.0134116","article-title":"The evolution of stomach acidity and its relevance to the human microbiome","volume":"10","author":"Beasley","year":"2015","journal-title":"PLoS ONE"},{"key":"2026020303203345200_jvim14779-bib-0026","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1208\/s12248-015-9743-7","article-title":"Applying biopharmaceutical classification system (BCS) criteria to predict oral absorption of drugs in dogs: Challenges and pitfalls","volume":"17","author":"Papich","year":"2015","journal-title":"AAPS J"},{"key":"2026020303203345200_jvim14779-bib-0027","first-page":"87","article-title":"Canine and Feline Infectious Diseases","author":"Sykes","year":"2014"},{"key":"2026020303203345200_jvim14779-bib-0028","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020303203345200_jvim14779-bib-0029","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2460\/javma.1998.213.05.658","article-title":"Blastomycosis in dogs: 115 cases (1980\u20131995)","volume":"213","author":"Arceneaux","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303203345200_jvim14779-bib-0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1939-1676.1996.tb02082.x","article-title":"Treatment of blastomycosis with itraconazole in 112 dogs","volume":"10","author":"Legendre","year":"1996","journal-title":"J Vet Intern Med"},{"key":"2026020303203345200_jvim14779-bib-0031","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/j.1875-9114.1998.tb03856.x","article-title":"Food interactions and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers","volume":"18","author":"Barone","year":"1998","journal-title":"Pharmacotherapy"},{"key":"2026020303203345200_jvim14779-bib-0032","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jps.21499","article-title":"Factors influencing the gastric residence of dosage forms in dogs","volume":"98","author":"Martinez","year":"2009","journal-title":"J Pharm Sci"},{"key":"2026020303203345200_jvim14779-bib-0033","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-199936030-00004","article-title":"Drug, meal and formulation interactions influencing drug absorption after oral administration","volume":"36","author":"Fleisher","year":"1999","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.14779","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/31\/4\/1163\/66669057\/jvim14779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/31\/4\/1163\/66669057\/jvim14779.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:20:43Z","timestamp":1770106843000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/31\/4\/1163\/8449470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.14779","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7]]},"published":{"date-parts":[[2017,7,1]]}}}